Glaucocalyxin B Alleviates Lipopolysaccharide-Induced Parkinson’s Disease by Inhibiting TLR/NF-κB and Activating Nrf2/HO-1 Pathway

Background/Aims: Parkinson’s disease (PD) is a common neurodegenerative disease in the old population, characterized by dopaminergic neuron loss, inflammation and oxidative stress injury in the substantia nigra. Glaucocalyxin B (GLB), an ent-kauranoid diterpenoid isolated from Rabdosia japonica, has...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Wei Xu, Deyu Zheng, Yuanyuan Liu, Ji Li, Li Yang, Xiuli Shang
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Cell Physiol Biochem Press GmbH & Co KG 2017-12-01
Cyfres:	Cellular Physiology and Biochemistry
Pynciau:	Parkinson’s disease Glaucocalyxin B Toll-like receptor Nuclear factor kappa B Nuclear factor erythroid 2-related factor 2
Mynediad Ar-lein:	https://www.karger.com/Article/FullText/485947
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!